Searched for
KWIKPEN
2025 in the rearview: A year of tumult and triumphIndia's economy in 2025 faced challenges from US tariffs and foreign investor exits. Despite these, domestic demand and reforms fueled stro...30 Dec, 2025, 08.21 AM IST- Intense Lilly, Novo rivalry throws India weight-loss drug race wide openEli Lilly and Novo Nordisk are in a race to dominate India's booming obesity drug market. They are using aggressive marketing, doctor outre...24 Dec, 2025, 07.09 AM IST
- Cipla launches drug for obesity, diabetesCipla has launched Yurpeak, a new injectable medication for obesity and type-2 diabetes. This one-weekly therapy, tirzepatide, is now avail...10 Dec, 2025, 07.34 PM IST
- Eli Lilly wants to be part of making a big dent in obesity and diabetes, says co's India head Winselow TuckerEli Lilly India chief Winselow Tucker said the company’s strategy of combining a strong product with ecosystem partnerships and patient edu...19 Nov, 2025, 07.05 PM IST
- Novo Nordisk slashes Wegovy prices in India by up to 37% to boost sluggish sales of weight-loss drugAccording to renowned endocrinologist Dr Shashank Joshi, a steep cut in the prices of Wegovy will help improve access and affordability. “B...11 Nov, 2025, 08.41 PM IST
- What’s powering Mounjaro’s rise to the top of Indian drug marketMounjaro has made a splash in Indian healthcare, emerging as the go-to solution for both diabetes management and weight loss. This remarkab...03 Nov, 2025, 10.47 PM IST
- Cipla to sell Lilly's weight-loss drug in IndiaEli Lilly and Cipla have joined forces. Cipla will now market Lilly's popular weight-loss drug in India. The medication will be sold under ...24 Oct, 2025, 02.51 PM IST
- Lilly, Cipla ink distribution pact for weight loss, type 2 diabetes treatment drug YurpeakIn an exciting collaboration, Cipla and Eli Lilly have unveiled Yurpeak, a groundbreaking diabetes and weight management medication, now av...23 Oct, 2025, 08.32 PM IST
- Eli Lilly's obesity drug Mounjaro's India sales hit a sweet spot within six months of launchLilly's Mounjaro has rapidly become the second-highest selling drug in India's pharmaceutical market, achieving ₹233 crore in sales within ...08 Oct, 2025, 06.07 AM IST
- WHO adds popular weight-loss drugs to essential medicines listThe World Health Organization has included Semaglutide and Tirzepatide, popular weight-loss drugs, in its Model List of Essential Medicines...10 Sep, 2025, 03.01 PM IST
- Eli Lilly launches Mounjaro KwikPen for diabetes, obesity treatment in IndiaEli Lilly has launched Mounjaro in KwikPen, a prefilled pen for weekly administration, in India to treat type 2 diabetes and obesity. Price...13 Aug, 2025, 07.33 PM IST
- Eli Lilly to roll out diabetes medicine in prefilled penEli Lilly will soon launch Mounjaro KwikPen in India. This follows regulatory approval for the diabetes and obesity drug. The KwikPen offer...08 Jul, 2025, 01.11 PM IST
- Eli Lilly to launch Mounjaro KwikPen for type 2 diabetes in IndiaEli Lilly is set to launch Mounjaro in KwikPen, a user-friendly, prefilled pen for weekly administration, in India, following regulatory ap...08 Jul, 2025, 01.10 PM IST
- Lilly to launch Mounjaro pen in India to compete with Novo's WegovyEli Lilly announced that India’s drug regulator has approved its Mounjaro KwikPen, a pre-filled injector pen for weight loss and diabetes t...26 Jun, 2025, 01.15 PM IST
Load More
